Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
Clinical trial NCT05472324 · COMPLETED
Trial details
- NCT number
- NCT05472324
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2025-03-05
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.